Posted by Michael Wonder on 01 Dec 2021
ICER publishes first annual assessment of barriers to fair access within US commercial insurance prescription drug coverage
1 December 2021 - Scope of assessment limited by gaps in availability of payer policies and inability to evaluate how policies are implemented, highlighting importance of improving transparency to assure fair access.
The Institute for Clinical and Economic Review today published its first annual “Barriers to Fair Access” assessment of prescription drug coverage policies.
